ORBIMED ADVISORS LLC purchased 34.2% of their position (190.67K shares) of MBX BIOSCIENCES, INC. on the open market
Open‑market purchase worth $2.02M — a major conviction buy. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 2/19/2025ACC: 0000947871-25-000199
Director10% Owner
Since Sep 2024
+190.67K
Net shares
Net buyer
$2.02M
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
190.67K acquired
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+17.96K
Price / share
$9.90
Trade value
$177.82K
% of position
0.6%
2/14/2025
3.16M→3.18M
Common Stock
Indirect
Shares
+29.54K
Price / share
$9.85
Trade value
$290.97K
% of position
0.9%
2/14/2025
3.18M→3.21M
Common Stock
Indirect
Shares
+49.07K
Price / share
$10.84
Trade value
$531.92K
% of position
1.5%
2/18/2025
3.21M→3.25M
Common Stock
Indirect
Shares
+94.10K
Price / share
$10.84
Trade value
$1.02M
% of position
14.4%
2/18/2025
653.79K→747.89K
Total
Net shares
+190.67K
Net value
$2.02M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/14/2025 | P · Purchase | +17.96K | $9.90 | $177.82K | 0.6% | 3.16M | 3.18M |
| Common Stock Indirect | 2/14/2025 | P · Purchase | +29.54K | $9.85 | $290.97K | 0.9% | 3.18M | 3.21M |
| Common Stock Indirect | 2/18/2025 | P · Purchase | +49.07K | $10.84 | $531.92K | 1.5% | 3.21M | 3.25M |
| Common Stock Indirect | 2/18/2025 | P · Purchase | +94.10K | $10.84 | $1.02M | 14.4% | 653.79K | 747.89K |
| Total | +190.67K | $2.02M | ||||||
Derivative Transactions0
No derivative transactions reported